FODDAI, SILVIA GRAZIETTA
 Distribuzione geografica
Continente #
NA - Nord America 828
EU - Europa 772
AS - Asia 346
SA - Sud America 74
AF - Africa 16
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.040
Nazione #
US - Stati Uniti d'America 762
IT - Italia 316
CN - Cina 151
IE - Irlanda 85
ES - Italia 81
SG - Singapore 81
MX - Messico 51
DE - Germania 42
SE - Svezia 41
FR - Francia 29
RU - Federazione Russa 29
IN - India 26
BR - Brasile 22
FI - Finlandia 22
GB - Regno Unito 22
ID - Indonesia 18
RO - Romania 15
CO - Colombia 13
PL - Polonia 13
AR - Argentina 12
HK - Hong Kong 11
JP - Giappone 10
VN - Vietnam 9
EC - Ecuador 8
KR - Corea 8
NL - Olanda 8
PE - Perù 8
PT - Portogallo 8
AT - Austria 7
CA - Canada 7
CH - Svizzera 7
HU - Ungheria 7
TR - Turchia 7
UA - Ucraina 7
IL - Israele 6
BE - Belgio 5
CL - Cile 5
CZ - Repubblica Ceca 5
DZ - Algeria 5
MA - Marocco 5
TW - Taiwan 5
EG - Egitto 4
IR - Iran 4
MT - Malta 4
RS - Serbia 4
SI - Slovenia 4
VE - Venezuela 4
AU - Australia 3
CR - Costa Rica 3
DK - Danimarca 3
GR - Grecia 3
SA - Arabia Saudita 3
AM - Armenia 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LV - Lettonia 2
PH - Filippine 2
TN - Tunisia 2
BO - Bolivia 1
CU - Cuba 1
EU - Europa 1
GT - Guatemala 1
IQ - Iraq 1
LT - Lituania 1
MY - Malesia 1
NI - Nicaragua 1
PK - Pakistan 1
UY - Uruguay 1
Totale 2.040
Città #
Chandler 146
Dublin 85
Turin 73
Singapore 64
Sesto San Giovanni 63
Ann Arbor 45
Torino 44
Ashburn 40
Beijing 36
Fairfield 32
Medford 30
Nyköping 30
New York 26
Wilmington 23
Madrid 21
Jakarta 18
Paris 18
Princeton 17
Rome 17
Hangzhou 16
Mexico City 15
Córdoba 13
Helsinki 13
Milan 13
Los Angeles 12
Chicago 11
Santa Clara 11
Falls Church 10
Hebei 10
Houston 10
Seattle 10
Bologna 9
Guiyang 9
Redwood City 9
Dong Ket 8
Cambridge 7
Cuenca 7
Hong Kong 7
Jacksonville 7
Lisbon 7
Seoul 7
Shanghai 7
Berlin 6
Lima 6
Mexico 6
San Diego 6
Seville 6
Vienna 6
Wroclaw 6
Wuhan 6
Bari 5
Bengaluru 5
Brussels 5
Budapest 5
Chengdu 5
Chongqing 5
Frankfurt am Main 5
Guadalajara 5
Mumbai 5
Novosibirsk 5
Ravenna 5
Terrassa 5
Toronto 5
Valencia 5
Washington 5
Acton 4
Belgrade 4
Brescia 4
Bucaramanga 4
Bucharest 4
Delhi 4
Ecatepec 4
Freiburg im Breisgau 4
Hyderabad 4
Lappeenranta 4
Ljubljana 4
Padova 4
San Francisco 4
Sheffield 4
Syracuse 4
Vitória 4
Woodbridge 4
Yuncheng 4
Athens 3
Barcelona 3
Brasov 3
Carate Brianza 3
Cuauhtemoc 3
Granada 3
Gżira 3
Jerusalem 3
Leidschendam 3
Medina 3
Norwalk 3
Piazzola sul Brenta 3
Pontevedra 3
Providence 3
Pune 3
Remedios de Escalada 3
Riverton 3
Totale 1.302
Nome #
Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome 260
Treatment of antiphospholipid syndrome 258
Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring 218
Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 103
Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss 102
Tailoring tofacitinib oral therapy in rheumatoid arthritis: The TuTORApp—a usability study 93
Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS) 84
Improving the clinical accuracy in patients with antiphospholipid antibodies using anti-phosphatidylserine/prothrombin and anti-beta2 glycoprotein I domain and particle-based multi-analyte technology 82
Impact of the new 2019 EULAR/ACR classification criteria for Systemic Lupus Erythematosus in a multicenter cohort study of 133 women with undifferentiated connective tissue disease 78
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) 68
Antiphosphatidylserine/Prothrombin Antibodies: An Update on Their Association with Clinical Manifestations of Antiphospholipid Syndrome 65
Genetic factors in antiphospholipid syndrome: Preliminary experience with whole exome sequencing 64
Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation 64
The prevalence of antiphospholipid antibodies in women with late pregnancy complications and low-risk for chromosomal abnormalities 62
Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies 58
Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study 53
A multicentre study of 244 pregnancies in undifferentiated connective tissue disease: maternal/fetal outcomes and disease evolution 47
"How we treat" clinical dilemmas in antiphospholipid syndrome: A case-based approach 44
Validation of the particle-based multi-analyte technology for detection of anti-phosphatidylserine/ prothrombin antibodies 39
Detection of Autoantibodies in Saliva as New Avenue for the Diagnosis and Management of Autoimmune Patients 30
Assessing the cardiovascular risk in patients with systemic lupus erythematosus: QRISK and GAPSS scores head-to-head 29
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study 29
Thrombin generation assay and lupus anticoagulant synergically distinguish populations of patients with antiphospholipid antibodies 28
Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet’s Disease: A Systematic Review 21
Serum Biomarkers of Renal Fibrosis: A Systematic Review 19
2023 ACR/EULAR classification criteria in existing research cohorts: an international study 17
New Frontiers in Autoimmune Diagnostics: A Systematic Review on Saliva Testing 16
Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients 16
Assessing the steroid-sparing effect of biological agents in randomized controlled trials for lupus: a scoping review 13
Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS) (vol 122, pg 1612, 2022) 9
Thrombosis and APS: Lessons Learned from Another Black Swan Tale 8
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab 8
Pursuing appropriateness in antiphospholipid antibodies testing: Feasibility study with a reflex test approach for anti-β2GPI I domain 5
Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence 2
Totale 2.092
Categoria #
all - tutte 8.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 4 1 2 0 1 5
2020/2021126 2 9 12 7 11 9 2 14 20 10 8 22
2021/2022375 17 35 34 13 43 30 26 17 28 19 47 66
2022/2023703 57 66 40 54 69 128 63 54 51 23 60 38
2023/2024698 61 73 66 35 80 73 37 41 19 55 37 121
2024/2025177 55 58 46 18 0 0 0 0 0 0 0 0
Totale 2.092